Deutsche Bank Ag\ Edesa Biotech, Inc. Transaction History

Deutsche Bank Ag\

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$1.64 - $4.09 $16,413 - $40,932	-10,008 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.94 - $6.42 $34,853 - $56,791	8,846 Added 761.27%	10,008 $41,000
Q3 2019 Nov 14, 2019	BUY	$3.39 - $7.52 $3,939 - $8,738	1,162 New	1,162 $7,000

Ticker EDSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,462,300
Market Cap $28.6M
Description
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.